APA (7th ed.) Citation

Kocks, J. W. H., Harrison, T., Bell, J. P., Rignall, A., Khezrian, M., & Usmani, O. S. (2026). Global pMDI Use and the Potential Impact of European PFAS Legislation on Access to These Essential Inhaled Medications. Pulmonary Therapy, 12(2), 653. https://doi.org/10.1007/s41030-026-00362-1

Chicago Style (17th ed.) Citation

Kocks, Janwillem W. H., Tim Harrison, John P. Bell, Andy Rignall, Mina Khezrian, and Omar S. Usmani. "Global PMDI Use and the Potential Impact of European PFAS Legislation on Access to These Essential Inhaled Medications." Pulmonary Therapy 12, no. 2 (2026): 653. https://doi.org/10.1007/s41030-026-00362-1.

MLA (9th ed.) Citation

Kocks, Janwillem W. H., et al. "Global PMDI Use and the Potential Impact of European PFAS Legislation on Access to These Essential Inhaled Medications." Pulmonary Therapy, vol. 12, no. 2, 2026, p. 653, https://doi.org/10.1007/s41030-026-00362-1.